BioRestorative Therapies to Seek FDA Approval to Expand the Clinical Application of BRTX-100

BioRestorative Therapies, Inc. announced that it has entered into an agreement with the Bruder Consulting & Venture Group to assist the company in seeking FDA approval for the expansion of the clinical application of BRTX-100.